Dr. John Cush RheumNow
5 years 1 month ago
Bone marrow cell vacuolation in VEXAS https://t.co/j0rGngjJZA
Dr. John Cush RheumNow
5 years 1 month ago
US News & World Report Ranks Best Rheumatology Hospitals
Did your hospital make the list?
https://t.co/DgoE0On7So https://t.co/B9NXJ8W4xl
Mike Putman EBRheum
5 years 1 month ago
Important read re:G6PD testing prior to HCQ
Rare & not assoc w/hemolytic anemia in this cohort, but only 11 pts with G6PDH deficiency
I'm v. skeptical of G6PD screening; cost (no HCQ in SLE) could easily be worse than benefit (avoiding hemolytic anemia)
Do you routinely test? https://t.co/HI2PuF1Xq9
k dao KDAO2011
5 years 1 month ago
Check for APAs and LAC in SLE pts with hemolytic anemia https://t.co/hlGfnq89Pz
Peter Nash drpnash
5 years 1 month ago
Oligoarticular Versus Polyarticular Psoriatic Arthritis: A Longitudinal Study Showing Similar Characteristics https://t.co/bIPdfUIL5S via @docguide 39% oligo progress to poly - what about response to therapy - likely the same?
Dr. John Cush RheumNow
5 years 1 month ago
Using data from Framingham Study, 347 pt w/ Widespread Pain (WP) compared to 2117 without. WP was associated with an increased risk of all-cause dementia (HR: 1.43), Alzheimer's (HR: 1.47) and stroke risk (HR: 1.29). https://t.co/S1CS01zNkJ
The American College of Rheumatology (ACR) is actively engaged with the FDA Center for Drug Evaluation and Research (CDER) drug shortage team as they work with the manufacturer to resolve current shortages of tocilizumab (Actemra).
Nonserious infections (NSI) comprise the bulk of all infections seen with biologic therapies; new data from British Society for Rheumatology Biologics Register for Rheumatoid Arthritis shows that while NSI are more common than serious infections, the predictors of NSI are the same as serious infections.
Dr. John Cush RheumNow
5 years 1 month ago
Sporadic reports of anakinra use in COVID-19 infection has hinted is potential; now a metanalysis shows that the use of anakinra may reduce the mortality risk in patients admitted to hospital with moderate to severe COVID-19 pneumonia.
https://t.co/VBxg9fQmt0 https://t.co/ARX2C0WRJ1
Dr. John Cush RheumNow
5 years 1 month ago
Analysis of 7815 RA patients (female, 85%) w/ 340 H. Zoster events (309 pts). HZ rates were lower in men vs women 8.5 vs 11 HZ/1000 Pt-Yrs. Zoser Risk factors: incr HAQ (OR 1.51), MTX use (1.58), and biologic use (1.88) https://t.co/p0MTlwgJ8g
Conclusions
Dr. John Cush RheumNow
5 years 1 month ago
Among a cohort of first-degree relatives of patients with rheumatoid arthritis (RA), certain patient characteristics, as well as symptoms, helped predict a possible increased risk for developing the disease, U.K. researchers reported.
https://t.co/7geaJDO8O8 https://t.co/opIu4gXxin
Dr. John Cush RheumNow
5 years 1 month ago
https://t.co/lRr1EsoADU
EULAR 2021: Still’s Disease Highlights Sponsored by Novartis Medical Affairs Listen to a discussion of medical experts discuss insights from independently selected abstracts in Still’s disease.
Dr. John Cush RheumNow
5 years 1 month ago
16 Pts on mech ventilation for SARS-CoV-2- induced ARDS with hyperinflammation were treated with ruxolitinib plus standard care - 13/16 survived 28 days. Better outcomes seen w/ RUX and Lymph-neutrophil ration > 0.07. https://t.co/4O2Y5swE0x
Shematologist, MD acweyand
5 years 1 month ago
In the week ending 8/12:
👧🏽121,427 pediatric #COVID19 cases
(14.4% of all cases, 49 states)
🏥452 pediatric hospitalizations (24 states reporting)
💀7 pediatric deaths (43 states reporting)
One death is too many.
Adam Cifu adamcifu
5 years 1 month ago
Here is a fairly obvious piece of advice: If a patient presents with a diagnosis (self-made) rather than a symptom, work hard to clarify the symptom itself. You usually make the same diagnosis but not always...
